🇺🇸 FDA
Patent

US 12312616

CRISPR-Cas effector polypeptides and methods of use thereof

granted A61KA61K31/7088A61K38/00

Quick answer

US patent 12312616 (CRISPR-Cas effector polypeptides and methods of use thereof) held by The Regents of the University of California expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/7088, A61K38/00, A61K38/465, A61K48/00